Mersana Therapeutics
MRSN
MRSN
152 hedge funds and large institutions have $590M invested in Mersana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 37 reducing their positions, and 20 closing their positions.
Holders
152
Holders Change
–
Holders Change %
0%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
20
Increased
68
Reduced
37
Closed
20
Calls
$512K
Puts
$469K
Net Calls
+$43K
Net Calls Change
-$55K
Top Buyers
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$195K |
| 2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$2.7M |
| 3 |
UOC
3
UBS O'Connor
Chicago,
Illinois
|
$0 |
| 4 |
4
Goldman Sachs
New York
|
$11.8M |
| 5 |
5
D.E. Shaw & Co
New York
|
$13.7M |
